The latest biotechnology news | Bio News
dimitri-karastelev-G9bYdOIBJq0-unsplash

Gilead’s anti-COVID Veklury reduces risk of death

Starting Veklury (remdesivir) within the first two days of hospitalization for COVID-19 can ...
Read More
01-maternal-RSV-jab

Pfizer’s RSV vaccine for infants could be approved this summer

Pfizer’s vaccine aimed at protecting infants against severe respiratory syncytial virus (RSV) could ...
Read More
calf-g3b7963e2a_1280

Acceligen’s gene-edited calf less susceptible to BVDV

Biotechnology Innovation Organization (BIO) member Acceligen partnered with the USDA’s Agricultural Research Service ...
Read More
NCBAscreenshot

NCBA understands that, in Black America, health care is holistic

“You know,” Karyne Jones laughs, “I am about the same age as many ...
Read More
poplar-seedling-Living-Carbon

Biotech helps to fight climate change with carbon-devouring GM trees

A California biotech company seeking to help fight climate change is using the ...
Read More
Long-COVID-webinar-3

BIO’s long COVID webinar furthers search for biotech solutions

When it comes to long COVID, health care providers and the biotech industry ...
Read More
Save with Avantor and BIO Business Solutions

EDITORS' CHOICE

Crowley PBMs

BIO CEO testifies in hearing highlighting PBMs’ impact on drug prices

Pharmacy benefit managers (PBMs) were identified as a major driver behind higher prescription drug costs in a congressional hearing that featured testimony from BIO President ...
Read More

LATEST NEWS

Federal Policy

BIO Patient Advocacy Coffee Chat: Act now to be heard on CMS drug pricing

The Medicare drug price “negotiation” process has entered its third year, with some evolution but continued complexity for patients and patient organizations. This year, 15 ...
BIO Events

Meet us in Miami for the BIO Investment and Growth Summit

The inaugural Biotechnology Innovation Organization (BIO) Investment and Growth (BIG) Summit kicks off on March 2, 2025, and will convene industry leaders in sunny Miami ...
Latest News

BIO warns MFN models are illegal, ineffective, and a threat to innovation

Proposals to let decisions by other countries control American drug prices are illegal, would reduce the availability of innovative new treatments, and fail to help ...
Health

Music Beats Cancer aims to bring everyone to the stage

The Valley of Death is a healthcare crisis, but the nonprofit, Music Beats Cancer, has an innovative way to help solve it, and it starts ...
BIO Events

The BIG Summit meets at the intersection of patient advocacy and venture investment

Patient advocacy organizations that leverage venture philanthropy—an approach to philanthropic giving that applies venture capital principles to achieve philanthropic goals—can provide vital funding sources for ...

Welcome, John F. Crowley!

Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.

Federal Policy

State Policy

International

Bio's View

Scroll to Top